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OBJECTIVES: This study analyzes hemodynamic changes in patients with cardiac valvular diseases submitted to dental treatment 
under local anesthesia containing epinephrine. 
METHODS: This randomized clinical trial was performed at the Dental Division of the Instituto do Coração do Hospital das 
Clínicas da Faculdade de Medicina da Universidade de São Paulo (Brazil). Patients were separated into two groups with the help 
of an aleatory number table: 2% plain lidocaine (PL, n= 31) and 2% lidocaine with epinephrine (1:100,000) (LE, n= 28). Blood 
pressure, heart rate, oxygenation and electrocardiogram data were all recorded throughout the procedure. State and trait anxiety 
levels were measured. 
RESULTS: Fifty-nine patients were selected for the LE group (n=28), with an average age of 40.3 ± 10.9, or for the PL group 
(n=31), age 42.2 ± 10.3. No differences were shown in blood pressure, heart rate and pulse oximetry values before, during and after 
local anesthesia injection between the two groups. State and trait anxiety levels were not different. Arrhythmias observed before 
dental anesthesia did not change in shape or magnitude after treatment. Complaints of pain during the dental procedure were more 
frequent within the PL group, which received a higher amount of local anesthesia. 
CONCLUSION: Lidocaine with epinephrine (1:100,000) provided effective local anesthesia. This treatment did not cause an 
increase in heart rate or blood pressure and did not cause any arrhythmic changes in patients with cardiac valvular diseases.
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INTRODUCTION
Pain and fear during dentistry procedures can be 
important factors that render the experience as an adverse 
event. In a study carried out by the Committee for the 
Prevention of Systemic Complications During Dental 
Treatment of the Japan Dental Society of Anesthesiology, 
it was observed that 60% of dental treatment complications 
involved neurogenic shock that happened, in most of the 
cases, as a result of dental extractions and endodontic 
procedures during or after anesthesia.1 Researchers 
observed a significant increase from 5 to 12 mmHg in the 
systolic blood pressure in patients submitted to root surface 
debridement without local anesthesia.2,3 
Patients with heart valvular disease constitute a group 
in which local anesthesia should be effective, considering 
that pain is responsible for the liberation of endogenous 
catecholamines that can activate hemodynamic disturbances, 
including increases in blood pressure, heart rate and the 
frequency of arrhythmias.4-11 
The epinephrine vasoconstrictor that is added to local 
anesthetics in dentistry treatment provides excellent 
anesthesia and bleeding control.5-7 Although its use in healthy 
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patients has become a common practice, the use in patients 
with cardiac diseases is still controversial. No significant 
hemodynamic response to lidocaine dental anesthesia (with 
or without epinephrine) was found in healthy young patients, 
but some degree of adrenergic activation was detected during 
minor oral surgery in volunteers and in cardiac transplant 
recipients.8-10
The purpose of this study was to investigate the safety 
and efficiency of 2% lidocaine with epinephrine (1:100,000) 
when compared to plain lidocaine in patients with valvular 
disease. To this end, we observed hemodynamic parameters, 
analyzed the electrocardiogram data and quantified clinical 
symptoms.
METHODS
This randomized clinical trial was performed in the 
Dental Division of the Instituto do Coração do Hospital 
das Clínicas da Faculdade de Medicina da Universidade 
de São Paulo (Brazil) (Clinical Trials, registry number 
NCT00669838). The study was previously approved by 
the local ethics committee. Patients were fully informed of 
the purposes of the study and the procedures involved, and 
written consent was obtained. Patients with acquired valvular 
disease, aged between 18-65 years and in need of dental 
surgery (tooth extraction) or mandibular restorative dentistry 
participated in this study. Patients exhibited a variety of 
valvular diseases: mitral double lesion, aortic double lesion, 
mitral stenosis, aortic stenosis, mitral regurgitation, aortic 
regurgitation, atrial fibrillation, tricuspid regurgitation, 
cardiac functional classification and mitral valve prolapse. 
Patients who had platelets counts lower than 70.000 or INR 
> 3 were excluded.12 
Participants were directed to maintain their routine 
medication regimen. They were allocated into two groups: 
LE (2% lidocaine with epinephrine [1:100,000]) and PL 
(2% lidocaine), according to a randomized table. Patients 
received prophylactic antibiotics following the American 
Heart Association guidelines.
The anesthetic was injected using the inferior alveolar 
nerve block technique with a slow infiltration (>60 
seconds). When a molar surgery was necessary, a quarter 
of the anesthetic cartridge was injected distal to the last 
molar in the mandible, in order to achieve buccal nerve 
anesthesia. 
All patients received one cartridge (1.8 ml) of the 
anesthetic solution immediately at the beginning of the 
procedure; further injections were applied according to 
patients’ symptoms or request. The cartridges were covered 
with a white strip to prevent patients and study administrators 
from reading any information pertaining to the anesthetic 
solution. These local anesthetics were prepared by a blinded 
professional.
Hemodynamic values including noninvasive blood 
pressure, heart rate, electrocardiograms of three derivations 
(D1, AVF and V1) and pulse oximetry were registered with 
a Dixtal DX2010 monitor (São Paulo- Brazil). The EKG 
data was recorded continually. All intervals were recorded 
to facilitate analysis of supraventricular and ventricular 
arrhythmic waves, as well as the ST segment. A cardiologist 
blinded to the procedure group analyzed the EKG data.
The patients were kept in a seated position at 45 
degrees for 15 minutes before the dental procedure; their 
hemodynamic values at the 1st and 15th minutes were 
recorded. These parameters were considered as basal values 
for the patient. During the procedure, measurements were 
taken every 5 minutes and also at 1 and 15 minutes after the 
end of the procedure.
The Spielberger State-Trait Anxiety Inventory (STAI) was 
used to measure anxiety levels. The STAI was administered 
to all patients prior to dentistry procedures in order to record 
any measurable anxiety.13 An additional questionnaire 
containing information about pain, dizziness, palpitation, 
diaphoresis, anxiety, angina, fainting and syncope was 
administered at the end of the procedure, in order to evaluate 
the stress experienced during the treatment.
At the end of the procedure, the patients were instructed 
to take notes for additional comparison among the groups. 
Statistical analysis
The presence of arrhythmia was considered as unknown 
before and as 90% after the procedure. The Yates correction 
factor was used for proportionate sample sizes, with the 
power of the test being 80% and alpha set to 0.05, resulting 
in 25 patients for each group.
The electrocardiogram events registered during 
interventions were compared by the McNemar test, 
considering the presence or absence of previous arrhythmias. 
We also performed a Kruskal-Wallis test to evaluate the 
arrhythmias within the LE and PL groups and a Mann-
Whitney test to compare the frequencies between the two 
groups. A Student’s t-test was used to compare the blood 
pressure and heart rate before and after the procedure. 
ANOVA for repeated measures was used to compare blood 
pressure and heart rate within a group during the procedure. 
Pulse oximetry values and anesthetic volumes were 
compared by a Mann-Whitney test; duration of anesthesia 
was compared using the t-test. Fisher’s exact test, as well as 
the STAI questionnaire, was used to determine the frequency 
of symptoms described by the patients during the procedure. 
Results were considered statistically significant at p < 0.05.
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RESULTS
Fifty-nine patients with valvular disease participated in 
this study. Their age (LE 40.3 ± 10.9 and PL 42.2 ± 10.3 
years), weight (LE 63.97 ± 19.32 and PL 59.44 ± 15.85 
kg) and height (LE 164 ± 09 and PL 161 ± 09 cm) did 
not differ, nor did the prevalence of valvular disease. The 
anesthesia duration for the LE group was longer (P=0.004) 
than that of the PL group (Table 1). Similarly, the number 
of local anesthesia cartridges used was higher in the PL 
group (3 cartridges for 75% of the cases, P=0.008). Blood 
pressure before and after the dental procedures, or during 
the treatment period, did not show any significant difference 
(Table 2, Figure 1).
The comparison of heart frequency among the two 
groups before (P =0.69) and after the procedure (P =0.87) 
indicated an absence of alterations in this variable for the 
volume of epinephrine used. The heart rhythm during the 
perioperative period also failed to exhibit alterations, with 
a P-value of 0.907 for the LE group and 1.000 for the PL 
group. The unaffected pulse oximetry values suggested that 
the patients did not have any breathing problems during the 
dental intervention.
Three statistical tests were used to analyze electro-
cardiographic alterations after the administration of local 
anesthesia. There was not any noticeable difference for any 
of the analyses performed among the groups, considering 
that the arrhythmias observed before the dental anesthesia 
did not change in form or amplitude after the anesthesia 
procedure. The McNemar test with the Yates correction for 
continuity showed no difference, considering five patients 
from the LE group with rhythmic heart rates that became 
arrhythmic (p=0.07) and three rhythmic heart rates among 
PL patients that became arrhythmic (p=0.5). The medians for 
irregular complexes among the PL and LE groups showed no 
difference when compared by a Mann-Whitney test. Finally, 
the medians for irregular complexes did not differ within a 
group when comparing the pre-, post- and intraoperative 
dental treatment values by Kruskal-Wallis one way analysis 
of variance (Table 3).
There was no difference in anxiety levels among the 
groups, either for state anxiety or trait anxiety (Table 1). 
Furthermore, the Fisher exact test results for symptoms 
showed no dissimilarities. However, when the pain was 
analyzed, the PL group presented more complaints as 
compared to the LE group (P=0.03). 
Table 1 - Demographic data, procedure and anesthetic length, STAI results and valvular disease distribution
PL (n=31) LE (n=28)
Age, years (mean ± SD) 42.1 ± 10.3 40.3 ± 10.9
Weight, kg (mean ± SD) 59.4 ± 15.8 63.1 ± 19.3
Height, cm (mean ± SD) 161 ± 09 164 ± 09
Procedure length (median [25-75%] 33.0 [27.5-41.0%] 39.5 [32.0-53.5%]
Anesthetic duration (mean ± SD) 111.6 ± 74.4* 175.5 ± 76.6
State-anxiety level (STAI) 36.1 ± 8.3 36.9 ± 9.1
Trait-anxiety level (STAI) 44.4 ± 11.6 42.1 ± 10.5
Mitral disease 22 22
Aortic disease 10 10
Tricuspid disease 4 3
* p < 0.004 (t-test)
Table 2 - Values (mean ± SD) for systolic, diastolic and median blood pressure, before and after dental procedure in the PL 
and LE groups
Variable LE PL LE PL
Heart Pressure (mmHg) Before dental procedure After dental procedure
Systolic 119.75 ± 24.03 124.61 ± 19.32 122.36 ± 4.98 127.16 ± 3.99
P-value 0.39 0.45
Diastolic 68.82 ± 13.36 71.77 ± 14.48 73.21 ± 19.42 75.71 ± 16.68
P-value 0.42 0.59
Mean 89.11 ± 15.94 93.87 ± 14.21 92.93 ± 23.50 9613 ± 16.07
P-value 0.23 0.54
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DISCUSSION
Local anesthetic consisting of 2% lidocaine and 
epinephrine [1:100,000] did not alter the previously 
registered arrhythmic conditions and did not change the heart 
rate or blood pressure among patients with cardiac valvular 
disease, suggesting its safety for use in minor dentistry 
interventions.
Epinephrine is one of the most commonly used 
vasoconstrictors in association with local anesthesia in 
dentistry; it is indisputably the most studied.6,7,14,15 Its use 
in dentistry, as well as that of other vasoconstrictors, is 
widely accepted. There are few studies in the literature 
that show its use in patients with valvular diseases, since 
most of those studies are performed in patients with 
hypertension and coronary artery disease.15,16 On the other 
hand, valvular diseases are involved in at least 18% of the 
ambulatory movements of a cardiology hospital and about 
30% of cardiac surgeries.17 Such patients invariably require 
additional unexpected procedures.
Adequate pain control is essential during dental 
procedures. The oral cavity is densely filled with pain-
triggering structures. Substances that provide more profound 
anesthesia are necessary to prevent stress. In addition, an 
increase in the heart rate by about 12 beats per minute can 
be caused by simply sitting down in the dental chair. A 
simple and brief talk with the dentist concerning the dental 
problem increases systolic blood pressure by approximately 
5 or 6 mmHg.4
In this study, the administration of local anesthesia 
without a vasoconstrictor drove more patients to complain 
of pain during dental surgery. Lidocaine alone exhibited 
unsatisfactory pain control; when combined with 
epinephrine, this same anesthetic provided a more intense 
blocking of large- and small-diameter nerve fibers.7,18,19 
Despite the absence of additional arrythmias or variations 
in heart rate or blood pressure, the PL group exhibited a 
higher cardiac rate and blood pressure than the LE group. 
This suggests that a fast-acting local anesthetic results in 
greater patient susceptibility to stress, requiring more careful 
attention from the dentist during dental treatment.
The findings of this study are in agreement with the 
results of other investigations in which patients with 
cardiac problems received 2% lidocaine with epinephrine 
(1:100,000) during dental treatment and hemodynamic 
parameters did not change significantly.7,15,20-24 We observed 
no increase in any symptoms in the LE group, in accordance 
with a previous study in which the patients did not show 
any symptoms during treatment with a local anesthetic that 
contained a vasoconstrictor.15 
Epinephrine is an arrhythmogenic substance. However, 
there is no consensus regarding the amount of this 
catecholamine to be used in dentistry in order to maintain 
a margin of safety with cardiac patients. The present study 
One-Way Repeated Measures Analysis of Variance: PL, p=0.85; LE, p=0.67.
Figure 1 - Mean arterial pressure for PL (mean - SD) and LE groups (mean 
+ SD) throughout the procedure
Table 3 - Number of irregular complexes during dental treatment periods in the PL and LE groups (median [25%-75%])
Arrhythmias LE (n=28) PL (n=31) Mann-Whitney (p)
Supraventricular
Pre-operative 1.00 [1.00 – 1.10] 1.00 [1.00 – 1.10] 0.57
Intraoperative 1.00 [1.00 – 1.22] 1.00 [1.00 – 1.10] 0.96
Post-operative 1.00 [1.00 – 1.10] 1.00 [1.00 – 1.02] 0.56
Kruskal-Wallis (p) 0.91 0.42
Ventricular
Pre-operative 1.00 [1.00 – 1.10] 1.00 [1.00 – 1.10] 0.67
Intraoperative 1.00 [1.00 – 1.00] 1.00 [1.00 – 1.35] 0.10
Post-operative 1.00 [1.00 – 1.00] 1.05 [1.00 – 1.10] 0.09
Kruskal-Wallis (p) 0.33 0.39
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evaluated the continuous recordings of electrocardiograms 
before, during and after the dental procedure. The 
arrhythmias observed were analyzed according to frequency, 
form and amplitude, as well as depression of the ST 
segment. Cardiac patients exhibit frequent arrhythmias due 
to their established cardiac condition; the injection of a local 
anesthetic containing epinephrine did not alter these existing 
conditions. These findings are in accordance with other 
studies in which ST depression was not observed during 
dental treatment of cardiac patients when utilizing a local 
anesthetic that contained a vasopressor. 11 Blinder et al. 
analyzed the ST depression, cardiac rhythm and the number 
of premature heart beats in cardiac patients submitted 
to dental extractions under a local anesthetic containing 
a vasopressor. When the local anesthetic contained a 
vasopressor, there was a high incidence of tachycardia 
but less arrhythmia or ST depression, as compared with a 
previous study that used anesthetic alone.16,25 
The present data indicate that the use of 2% lidocaine 
with epinephrine (1:100,000) in patients with valvular 
disease represents a safe and effective anesthetic procedure. 
There were no additional significant alterations in the 
electrocardiogram data and no increase in blood pressure 
with this treatment. This group of cardiac patients 
experienced a more profound anesthesia and apparently 
remained more comfortable and free of pain.
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